Tuesday, September 22, 2009

Mkt Up, Stem Cells Down Tuesday 9.22 - BSDM up 103%

Tuesday 9.22.09:
DOW +51(.5%) @9,830..NAS +8.26(.39%) @2,146..SP500 +7(.66%) @1,072

BIO-Stem Index:-.69(.46%) @148.95 (+48.95% ytd)
BIO-ETF Index:-1.55(-1.32%) @115.93 (+15.93% ytd)
[Stem cell index beating biotech by 28.4%]

Tuesday the market regained Monday's slight drop, with all 3 indices up about a half percent. Stem cells reversed yesterday's count, 12 up and 19 down. The big news was BSD Medical (BSDM), up 103%, which had positive results on ovarian tumors with their devices that use heat and electromagnetic waves along with traditional chemo, and 38% of the patients showed improvement in a Phase 3 trial. We bought some late in the day after price settled back down to 3.83 at the close. the Reuters story here..

CelSci (CVM) didn't give back much today, just 2.6%, considering it's recent run due to its more general flu vaccine, and government interest. Today, stem cell index didn't fall but 1/3 as much as the biotech ETFs, which gave back yesterday's gain.

Stem Cell Stocks (12 up, 19 down)
Big Winners:CYTX +11.5%, DGX 3.4%, OSTE +3%,
Losers: ARIA -6.1%, CUR 5.8%, OPXA -4.2%

Swine Flu Stocks
AVII +1.1%, BCRX -4.2%, DVAX -6.5%, GILD -1.1%, INHX +4.35%, INO -2.2%, NVAX -4%, SIGA -1.7%, SVA -1.9%
Other Flu: APT -5.6%, CVM -2.6%, PURE +4.1%

Other Biotech
Big Winners: BSDM +104%, ANIK +5.4%, NKTR +9.4%, PARD +6.4%
Losers: DYAX -6.5%, KVA -5.5%, ONCY -11.1%, ONXX -3.4% (may have a legal fight with partner Bayer over a similar drug to theirs), PDLI -3.8%, PGNX -3.6%, RPRX -8%, SGMO -3.5%, SOMX -5.5%, THRX -4.1%

SubMicro: CEGE +9.1%, CPRX +4.2%, FMTI +9%, GETA +12%, HEPH -4.6%, ICAD +5.9%, RGN -6.8%, TGEN +15.5%, TRBN -7.2%, TRMS +6.5%, YMI +3.6%

Volume Up vs Daily Avg: CUR, DGX, DNDN, OSIR, CVM, ADLR, ALTH, BDSM (55x, 11m shrs, half its float), CRME, GSK, NKTR, PDLI, VVUS, WYE, GETA, KOOL
New Intraday Highs:ALXN, DNDN, CVM, SNY, EXEL, MED, MRX, NKTR, SGEN, GETA, PCYC

Disclosure: Long BSDM, CVM, KERX


0 comments:

Disclaimer

This is not a solicitation or recommendation to buy or sell any stock. We are not registered investment advisors, and the site does not receive any compensation for any posts, endorsements, or listings. All investments carry risk, and your own individual situation should determine your strategy. Only invest funds you can afford to lose.

The Author at EZines

STEM CELLS EXPRESS

Visitor Map

Related Sites

World Markets Summary

Why We Invest

A company issuing stock gets it's money when the stock goes public, called IPO for Initial Public Offering. However, if the stock takes off due to future expectations, the company can capitalize by issuing more stock and raising money near the current price, so investing in these small biotech companies increases their chances of succeeding by raising enough additonal capital that they don't need to take on debt.

Then when promising drugs are approved and released, the subsequent income produced drives the stock price higher, and all investors and employees benefit and can either invest more in the industry or perhaps realize a goal in life.

1000 DVDs to See

About Me

My Photo
Artist, author, composer, still not dead yet in the Georgia woods, seeking wisdom in the silence of nature (plus a daily movie!) Constantly seeking and finding the "little gods that walk among us"
©2009, William L. Sinclair, All Rights Reserved

  © Blogger template 'Froggy' by Ourblogtemplates.com 2008

Back to TOP